Vancomycin bactericidal activity as a predictor of 30-day mortality in patients with methicillin-resistant Staphylococcus aureus bacteremia

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 4, 2011, Pages 1819-1820

  Miyazaki, Motoyasu ^a   Takata, Tohru ^b   Yoshimura, Hisae ^b   Matsunaga, Akira ^b   Ohta, Daiki ^b   Ishikura, Hiroyasu ^b   Futo, Maki ^a   Hara, Shuji ^a   Kamimura, Hidetoshi ^a   Tamura, Kazuo ^c   Ngo, Dung ^d   Tsuji, Brian T ^d  

^a FUKUOKA UNIVERSITY   (Japan)

^b FUKUOKA UNIVERSITY HOSPITAL   (Japan)

^c FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TEICOPLANIN; VANCOMYCIN;

APACHE; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; DIALYSIS; GENE LOCUS; HUMAN; IN VITRO STUDY; KIDNEY FAILURE; LETTER; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROBABILITY; SHOCK; SURVIVAL RATE; UNIVARIATE ANALYSIS;

ANTI-BACTERIAL AGENTS; BACTEREMIA; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; VANCOMYCIN;

EID: 79953201543     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01536-10     Document Type: Letter

References (7)

1. Chang, F. Y., et al. 2003. Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study. Medicine (Baltimore) 82:333-339.
2. Lodise, T. P., et al. 2008. Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin. Antimicrob. Agents Chemother. 52:3315-3320.
3. Moise, P. A., G. Sakoulas, A. Forrest, and J. J. Schentag. 2007. Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteremia. Antimicrob. Agents Chemother. 51:2582-2586.
4. Moise-Broder, P. A., et al. 2004. Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy. Clin. Infect. Dis. 38:1700-1705.
5. Sakoulas, G., R. C. Moellering, Jr., and G. M. Eliopoulos. 2006. Adaptation of methicillin-resistant Staphylococcus aureus in the face of vancomycin therapy. Clin. Infect. Dis. 42(Suppl. 1):S40-S50.
6. Sakoulas, G., et al. 2004. Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. J. Clin. Microbiol. 42:2398-2402.
7. Soriano, A., et al. 2008. Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia. Clin. Infect. Dis. 46:193-200.